Global and United States DTP Vaccine Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 DTP Vaccine Product Introduction
• 1.2 Global DTP Vaccine Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global DTP Vaccine Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global DTP Vaccine Sales in Volume for the Year 2017-2028
• 1.3 United States DTP Vaccine Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States DTP Vaccine Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States DTP Vaccine Sales in Volume for the Year 2017-2028
• 1.4 DTP Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States DTP Vaccine in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of DTP Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 DTP Vaccine Market Dynamics
  • 1.5.1 DTP Vaccine Industry Trends
  • 1.5.2 DTP Vaccine Market Drivers
  • 1.5.3 DTP Vaccine Market Challenges
  • 1.5.4 DTP Vaccine Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 DTP Vaccine Market Segment by Type
  • 2.1.1 Pertussis
  • 2.1.2 Diphtheria
  • 2.1.3 Tetanus
• 2.2 Global DTP Vaccine Market Size by Type
  • 2.2.1 Global DTP Vaccine Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global DTP Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global DTP Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States DTP Vaccine Market Size by Type
  • 2.3.1 United States DTP Vaccine Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States DTP Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States DTP Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 DTP Vaccine Market Segment by Application
  • 3.1.1 Hospital
  • 3.1.2 Epidemic Prevention Station
  • 3.1.3 Village Health Room
• 3.2 Global DTP Vaccine Market Size by Application
  • 3.2.1 Global DTP Vaccine Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global DTP Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global DTP Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States DTP Vaccine Market Size by Application
  • 3.3.1 United States DTP Vaccine Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States DTP Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States DTP Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global DTP Vaccine Competitor Landscape by Company

• 4.1 Global DTP Vaccine Market Size by Company
  • 4.1.1 Top Global DTP Vaccine Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global DTP Vaccine Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global DTP Vaccine Sales by Manufacturer (2017-2022)
  • 4.1.4 Global DTP Vaccine Price by Manufacturer (2017-2022)
• 4.2 Global DTP Vaccine Concentration Ratio (CR)
  • 4.2.1 DTP Vaccine Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DTP Vaccine in 2021
  • 4.2.3 Global DTP Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global DTP Vaccine Manufacturing Base Distribution, Product Type
  • 4.3.1 Global DTP Vaccine Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers DTP Vaccine Product Type
  • 4.3.3 Date of International Manufacturers Enter into DTP Vaccine Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States DTP Vaccine Market Size by Company
  • 4.5.1 Top DTP Vaccine Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States DTP Vaccine Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States DTP Vaccine Sales by Players (2020, 2021 & 2022)

5 Global DTP Vaccine Market Size by Region

• 5.1 Global DTP Vaccine Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global DTP Vaccine Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global DTP Vaccine Sales in Volume by Region: 2017-2022
  • 5.2.2 Global DTP Vaccine Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global DTP Vaccine Market Size in Value by Region (2017-2028)
  • 5.3.1 Global DTP Vaccine Sales in Value by Region: 2017-2022
  • 5.3.2 Global DTP Vaccine Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America DTP Vaccine Market Size YoY Growth 2017-2028
  • 6.1.2 North America DTP Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific DTP Vaccine Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific DTP Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe DTP Vaccine Market Size YoY Growth 2017-2028
  • 6.3.2 Europe DTP Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America DTP Vaccine Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America DTP Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa DTP Vaccine Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa DTP Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 SANOFI PASTEUR
  • 7.1.1 SANOFI PASTEUR Corporation Information
  • 7.1.2 SANOFI PASTEUR Description and Business Overview
  • 7.1.3 SANOFI PASTEUR DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 SANOFI PASTEUR DTP Vaccine Products Offered
  • 7.1.5 SANOFI PASTEUR Recent Development
• 7.2 NOVARTIS
  • 7.2.1 NOVARTIS Corporation Information
  • 7.2.2 NOVARTIS Description and Business Overview
  • 7.2.3 NOVARTIS DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 NOVARTIS DTP Vaccine Products Offered
  • 7.2.5 NOVARTIS Recent Development
• 7.3 Vaxelis
  • 7.3.1 Vaxelis Corporation Information
  • 7.3.2 Vaxelis Description and Business Overview
  • 7.3.3 Vaxelis DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 Vaxelis DTP Vaccine Products Offered
  • 7.3.5 Vaxelis Recent Development
• 7.4 GSK
  • 7.4.1 GSK Corporation Information
  • 7.4.2 GSK Description and Business Overview
  • 7.4.3 GSK DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 GSK DTP Vaccine Products Offered
  • 7.4.5 GSK Recent Development
• 7.5 Serum Institute of India
  • 7.5.1 Serum Institute of India Corporation Information
  • 7.5.2 Serum Institute of India Description and Business Overview
  • 7.5.3 Serum Institute of India DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 Serum Institute of India DTP Vaccine Products Offered
  • 7.5.5 Serum Institute of India Recent Development
• 7.6 Johnson & Johnson
  • 7.6.1 Johnson & Johnson Corporation Information
  • 7.6.2 Johnson & Johnson Description and Business Overview
  • 7.6.3 Johnson & Johnson DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.6.4 Johnson & Johnson DTP Vaccine Products Offered
  • 7.6.5 Johnson & Johnson Recent Development
• 7.7 Merck Sharp & Dohme Corp
  • 7.7.1 Merck Sharp & Dohme Corp Corporation Information
  • 7.7.2 Merck Sharp & Dohme Corp Description and Business Overview
  • 7.7.3 Merck Sharp & Dohme Corp DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.7.4 Merck Sharp & Dohme Corp DTP Vaccine Products Offered
  • 7.7.5 Merck Sharp & Dohme Corp Recent Development
• 7.8 Seqirus
  • 7.8.1 Seqirus Corporation Information
  • 7.8.2 Seqirus Description and Business Overview
  • 7.8.3 Seqirus DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.8.4 Seqirus DTP Vaccine Products Offered
  • 7.8.5 Seqirus Recent Development
• 7.9 Pfizer
  • 7.9.1 Pfizer Corporation Information
  • 7.9.2 Pfizer Description and Business Overview
  • 7.9.3 Pfizer DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.9.4 Pfizer DTP Vaccine Products Offered
  • 7.9.5 Pfizer Recent Development
• 7.10 Astrazeneca
  • 7.10.1 Astrazeneca Corporation Information
  • 7.10.2 Astrazeneca Description and Business Overview
  • 7.10.3 Astrazeneca DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.10.4 Astrazeneca DTP Vaccine Products Offered
  • 7.10.5 Astrazeneca Recent Development
• 7.11 astellas
  • 7.11.1 astellas Corporation Information
  • 7.11.2 astellas Description and Business Overview
  • 7.11.3 astellas DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.11.4 astellas DTP Vaccine Products Offered
  • 7.11.5 astellas Recent Development
• 7.12 Emergent BioSolutions Inc
  • 7.12.1 Emergent BioSolutions Inc Corporation Information
  • 7.12.2 Emergent BioSolutions Inc Description and Business Overview
  • 7.12.3 Emergent BioSolutions Inc DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.12.4 Emergent BioSolutions Inc Products Offered
  • 7.12.5 Emergent BioSolutions Inc Recent Development
• 7.13 WALVAX
  • 7.13.1 WALVAX Corporation Information
  • 7.13.2 WALVAX Description and Business Overview
  • 7.13.3 WALVAX DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.13.4 WALVAX Products Offered
  • 7.13.5 WALVAX Recent Development
• 7.14 Wuhan Institute of Biological Products Co.,Ltd.
  • 7.14.1 Wuhan Institute of Biological Products Co.,Ltd. Corporation Information
  • 7.14.2 Wuhan Institute of Biological Products Co.,Ltd. Description and Business Overview
  • 7.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.14.4 Wuhan Institute of Biological Products Co.,Ltd. Products Offered
  • 7.14.5 Wuhan Institute of Biological Products Co.,Ltd. Recent Development
• 7.15 Chengdu Institute of Biological Products Co.,Ltd.
  • 7.15.1 Chengdu Institute of Biological Products Co.,Ltd. Corporation Information
  • 7.15.2 Chengdu Institute of Biological Products Co.,Ltd. Description and Business Overview
  • 7.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.15.4 Chengdu Institute of Biological Products Co.,Ltd. Products Offered
  • 7.15.5 Chengdu Institute of Biological Products Co.,Ltd. Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 DTP Vaccine Industry Chain Analysis
• 8.2 DTP Vaccine Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 DTP Vaccine Distributors
• 8.3 DTP Vaccine Production Mode & Process
• 8.4 DTP Vaccine Sales and Marketing
  • 8.4.1 DTP Vaccine Sales Channels
  • 8.4.2 DTP Vaccine Distributors
• 8.5 DTP Vaccine Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details